Celgene Corporation
CELGENE CORP /DE/ (Form: 4, Received: 05/30/2013 17:33:04)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HUGIN ROBERT J
2. Issuer Name and Ticker or Trading Symbol

CELGENE CORP /DE/ [ CELG ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
see remarks
(Last)          (First)          (Middle)

C/O CELGENE CORPORATION, 86 MORRIS AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)

5/29/2013
(Street)

SUMMIT, NJ 07901
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/29/2013     M    1694   A $59.01   440713   D    
Common Stock   5/29/2013     M    232068   A $25.675   672781   D    
Common Stock   5/29/2013     M    24213   A $42.39   696994   D    
Common Stock   5/29/2013     M    24249   A $42.39   721243   D    
Common Stock   5/29/2013     M    68716   A $42.39   789959   D    
Common Stock   5/29/2013     M    1694   A $59.01   791653   D    
Common Stock   5/29/2013     M    25958   A $25.675   817611   D    
Common Stock   5/29/2013     F    242419   D $123.09   575192   D    
Common Stock   5/30/2013     S    68087   D $123.5772   (1) 507105   D    
Common Stock                  4800   I   By Children   (2)
Common Stock                  13473   I   401(k) Plan  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   $59.01   5/29/2013     M         1694      (3) 6/10/2013   Common Stock   1694   $0.00   (4) 0   D    
Stock Option (right to buy)   $25.675   5/29/2013     M         232068      (3) 6/10/2013   Common Stock   232068   $0.00   (4) 0   D    
Stock Option (right to buy)   $42.39   5/29/2013     M         24213      (3) 12/15/2013   Common Stock   24213   $0.00   (4) 0   D    
Stock Option (right to buy)   $42.39   5/29/2013     M         24249      (3) 9/15/2013   Common Stock   24249   $0.00   (4) 0   D    
Stock Option (right to buy)   $42.39   5/29/2013     M         68716      (3) 1/21/2014   Common Stock   68716   $0.00   (4) 0   D    
Stock Option (right to buy)   $59.01   5/29/2013     M         1694      (3) 1/21/2014   Common Stock   1694   $0.00   (4) 0   D    
Stock Option (right to buy)   $25.675   5/29/2013     M         25958      (3) 1/21/2014   Common Stock   25958   $0.00   (4) 0   D    

Explanation of Responses:
( 1)  The price reported in Column 4 is a weighted average price. These shares were sold pursuant to the reporting person's Rule 10b5-1 plan dated March 28, 2013 in multiple transactions at prices ranging from $122.66 to $124.56, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
( 2)  The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
( 3)  The option was fully exercisable.
( 4)  The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended).

Remarks:
Chairman of the Board of Directors, Chief Executive Officer and President

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HUGIN ROBERT J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT, NJ 07901
X
see remarks

Signatures
/s/Robert J Hugin___________________________ Robert J Hugin 5/30/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.